Speakers

Eric C. Leuthardt, MD, FNAI, Professor of Neurological Surgery, Neuroscience, Biomedical Engineering, Mechanical Engineering and Materials Science, Director of Center for Innovation in Neuroscience and Technology, Washington University in St. Louis http://www.neurosurgery.wustl.edu/patient-care/find-a-physician/clinical-faculty/eric-c-leuthardt-md-250

Creating environments for innovation in medical technology 

Mohamed Zayed, MD, PhD, RPVI, FSVS, FACS, Assistant Professor of Surgery, Vascular Surgery Section, Washington University in St. Louis https://surgery.wustl.edu/people/mohamed-zayed/

Can I make my device standout for treating pulmonary emboli?

Over 900,000 individuals per year will develop complications related to venous thromboembolism.  Nearly 50% of individuals that develop a pulmonary embolus will die within 2 weeks of diagnosis. There are currently a multitude of devices offered for the treatment of venous blood clots and compete over an annual $14 billion market.  My team and I are developing strategies on how to differentiate our product for the treatment of pulmonary emboli.

On the third Thursday of every month , ICTS Precision Medicine hosts a session featuring WashU faculty working in translational genomics/precision medicine areas. Talks are typically oriented toward biotechnology, diagnostics, informatics, start-ups and precision interventions based on medical genomics innovations.